KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Assets Average (2016 - 2025)

Historic Assets Average for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to $1.4 billion.

  • Emergent BioSolutions' Assets Average fell 378.43% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year decrease of 378.43%. This contributed to the annual value of $1.6 billion for FY2024, which is 3560.68% down from last year.
  • According to the latest figures from Q3 2025, Emergent BioSolutions' Assets Average is $1.4 billion, which was down 378.43% from $1.4 billion recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Assets Average ranged from a high of $3.1 billion in Q1 2023 and a low of $1.4 billion during Q1 2025
  • Moreover, its 5-year median value for Assets Average was $2.6 billion (2023), whereas its average is $2.3 billion.
  • In the last 5 years, Emergent BioSolutions' Assets Average soared by 2556.01% in 2021 and then crashed by 4070.08% in 2024.
  • Quarter analysis of 5 years shows Emergent BioSolutions' Assets Average stood at $2.9 billion in 2021, then increased by 4.07% to $3.0 billion in 2022, then tumbled by 38.7% to $1.9 billion in 2023, then decreased by 22.84% to $1.4 billion in 2024, then grew by 0.37% to $1.4 billion in 2025.
  • Its Assets Average stands at $1.4 billion for Q3 2025, versus $1.4 billion for Q2 2025 and $1.4 billion for Q1 2025.